Steroid anesthetics and naturally occurring analogs modulate the gamma- aminobutyric acid receptor complex at a site distinct from barbiturates

DM Turner, RW Ransom, JS Yang and RW Olsen

Department of Pharmacology, School of Medicine, University of California, Los Angeles.

The steroid anesthetic alphaxalone and a series of naturally occurring analogs were compared in potency and efficacy with each other and the hypnotic barbiturate pentobarbital for interaction with gamma- aminobutyric acid (GABA) receptors:binding sites in rat brain membranes and functional activity in 36Cl- flux measurements with rat hippocampal slices. The steroids enhanced [3H]muscimol binding to GABA receptor sites, enhanced [3H] flunitrazepam binding to benzodiazepine receptors and inhibited [35S]t-butyl bicyclophosphorothionate binding to picrotoxin/convulsant binding sites on the GABA receptor-chloride channel complex. The same steroids that were active in modulating the binding of ligands to the various receptor sites on the GABA receptor complex at micromolar concentrations enhanced muscimol-stimulated 36Cl- flux in rat hippocampal slices. The steroids, like the barbiturates, increased the maximal response to muscimol but produced little or no potentiation of basal 36Cl- flux in the absence of GABA agonist. Although the effects of steroids and barbiturates were similar, separate sites of action were demonstrated conclusively by the observation that the two classes of compounds, when included together, gave additive or synergistic effects on binding, as well as on 36Cl- flux in the absence of GABA agonist. Structure-activity studies showed that the synthetic steroid anesthetic alphaxalone was the most potent compound tested, followed by the naturally occurring steroids tetrahydro-deoxycorticosterone, allo-tetrahydrocorticosterone, cis- androsterone and 5 alpha-androstan-17 beta-ol-3-one. The ability of several naturally occurring steroids to enhance GABA-mediated inhibition in the brain suggests the possibility of an endogenous steroid modulator of neuronal function.

Volume 248, Issue 3, pp. 960-966, 03/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. W. McElroy and D. L. Korol Intrahippocampal muscimol shifts learning strategy in gonadally intact young adult female rats Learn. Mem., March 1, 2005; 12(2): 150 - 158. [Abstract] [Full Text] [PDF]

				L.-L. Wang, C.-C. Ou, and J. Y.H. Chan Receptor-Independent Activation of GABAergic Neurotransmission and Receptor-Dependent Nontranscriptional Activation of Phosphatidylinositol 3-kinase/Protein Kinase Akt Pathway in Short-Term Cardiovascular Actions of Dexamethasone at the Nucleus Tractus Solitarii of the Rat Mol. Pharmacol., February 1, 2005; 67(2): 489 - 498. [Abstract] [Full Text] [PDF]

				K. D. W. Morris and J. Amin Insight into the Mechanism of Action of Neuroactive Steroids Mol. Pharmacol., July 1, 2004; 66(1): 56 - 69. [Abstract] [Full Text] [PDF]

				D. Rusch, H. Zhong, and S. A. Forman Gating Allosterism at a Single Class of Etomidate Sites on {alpha}1{beta}2{gamma}2L GABAA Receptors Accounts for Both Direct Activation and Agonist Modulation J. Biol. Chem., May 14, 2004; 279(20): 20982 - 20992. [Abstract] [Full Text] [PDF]

				I. Spigelman, Z. Li, J. Liang, E. Cagetti, S. Samzadeh, R. M. Mihalek, G. E. Homanics, and R. W. Olsen Reduced Inhibition and Sensitivity to Neurosteroids in Hippocampus of Mice Lacking the GABAA Receptor {delta} Subunit J Neurophysiol, August 1, 2003; 90(2): 903 - 910. [Abstract] [Full Text] [PDF]

				R. Darbandi-Tonkabon, W. R. Hastings, C.-M. Zeng, G. Akk, B. D. Manion, J. R. Bracamontes, J. H. Steinbach, S. J. Mennerick, D. F. Covey, and A. S. Evers Photoaffinity Labeling with a Neuroactive Steroid Analogue. 6-AZI-PREGNANOLONE LABELS VOLTAGE-DEPENDENT ANION CHANNEL-1 IN RAT BRAIN J. Biol. Chem., April 4, 2003; 278(15): 13196 - 13206. [Abstract] [Full Text] [PDF]

				J.-J. Koksma, R. E. van Kesteren, T. W. Rosahl, R. Zwart, A. B. Smit, H. Luddens, and A. B. Brussaard Oxytocin Regulates Neurosteroid Modulation of GABAA Receptors in Supraoptic Nucleus around Parturition J. Neurosci., February 1, 2003; 23(3): 788 - 797. [Abstract] [Full Text] [PDF]

				L. R. McMahon and C. P. France Discriminative Stimulus Effects of Positive GABAA Modulators and Other Anxiolytics, Sedatives, and Anticonvulsants in Untreated and Diazepam-Treated Monkeys J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 109 - 120. [Abstract] [Full Text] [PDF]

				M. Wang, Y. He, L. N. Eisenman, C. Fields, C.-M. Zeng, J. Mathews, A. Benz, T. Fu, E. Zorumski, J. H. Steinbach, et al. 3beta -Hydroxypregnane Steroids Are Pregnenolone Sulfate-Like GABAA Receptor Antagonists J. Neurosci., May 1, 2002; 22(9): 3366 - 3375. [Abstract] [Full Text] [PDF]

				K. M. Wohlfarth, M. T. Bianchi, and R. L. Macdonald Enhanced Neurosteroid Potentiation of Ternary GABAA Receptors Containing the delta Subunit J. Neurosci., March 1, 2002; 22(5): 1541 - 1549. [Abstract] [Full Text] [PDF]

				C. E. Adkins, G. V. Pillai, J. Kerby, T. P. Bonnert, C. Haldon, R. M. McKernan, J. E. Gonzalez, K. Oades, P. J. Whiting, and P. B. Simpson alpha 4beta 3delta GABAA Receptors Characterized by Fluorescence Resonance Energy Transfer-derived Measurements of Membrane Potential J. Biol. Chem., October 12, 2001; 276(42): 38934 - 38939. [Abstract] [Full Text] [PDF]

				R. Nadeson and C. S. Goodchild Antinociceptive properties of neurosteroids III: experiments with alphadolone given intravenously, intraperitoneally, and intragastrically Br. J. Anaesth., May 1, 2001; 86(5): 704 - 708. [Abstract] [Full Text] [PDF]

				M. Orchinik, S. S. Carroll, Y.-H. Li, B. S. McEwen, and N. G. Weiland Heterogeneity of Hippocampal GABAA Receptors: Regulation by Corticosterone J. Neurosci., January 1, 2001; 21(1): 330 - 339. [Abstract] [Full Text] [PDF]

				A. K. Singh, B. D. Schultz, J. A. Katzenellenbogen, E. M. Price, R. J. Bridges, and N. A. Bradbury Estrogen Inhibition of Cystic Fibrosis Transmembrane Conductance Regulator-Mediated Chloride Secretion J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 195 - 204. [Abstract] [Full Text]

				K. E. Vanover, S. Rosenzweig-Lipson, J. E. Hawkinson, N. C. Lan, J. D. Belluzzi, L. Stein, J. E. Barrett, P. L. Wood, and R. B. Carter Characterization of the Anxiolytic Properties of a Novel Neuroactive Steroid, Co 2-6749 (GMA-839; WAY-141839; 3alpha , 21-Dihydroxy-3beta -trifluoromethyl-19-nor-5beta -pregnan-20-one), a Selective Modulator of gamma -Aminobutyric AcidA Receptors J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 337 - 345. [Abstract] [Full Text]

				H. E. Criswell, T. J. McCown, Z. Ming, R. A. Mueller, and G. R. Breese Interactive Role for Neurosteroids in Ethanol Enhancement of gamma -Aminobutyric Acid-Gated Currents from Dissociated Substantia Nigra Reticulata Neurons J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1054 - 1059. [Abstract] [Full Text]

				K. D. W. Morris, C. N. Moorefield, and J. Amin Differential Modulation of the gamma -Aminobutyric Acid Type C Receptor by Neuroactive Steroids Mol. Pharmacol., October 1, 1999; 56(4): 752 - 759. [Abstract] [Full Text]

				R. Chapell, O. F. Bueno, X. Alvarez-Hernandez, L. C. Robinson, and N. J. Leidenheimer Activation of Protein Kinase C Induces gamma -Aminobutyric Acid Type A Receptor Internalization in Xenopus Oocytes J. Biol. Chem., December 4, 1998; 273(49): 32595 - 32601. [Abstract] [Full Text] [PDF]

				M. Beekman, J. T. Ungard, M. Gasior, R. B. Carter, D. Dijkstra, S. R. Goldberg, and J. M. Witkin Reversal of Behavioral Effects of Pentylenetetrazol by the Neuroactive Steroid Ganaxolone J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 868 - 877. [Abstract] [Full Text]

				A. Sousa and M. K. Ticku Interactions of the Neurosteroid Dehydroepiandrosterone Sulfate with the GABAA Receptor Complex Reveals that it May Act via the Picrotoxin Site J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 827 - 833. [Abstract] [Full Text]

				J. A. Vivian, H. M. T. Barros, A. Manitiu, and K. A. Miczek Ultrasonic Vocalizations In Rat Pups: Modulation at the gamma -Aminobutyric AcidA Receptor Complex and the Neurosteroid Recognition Site, J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 318 - 325. [Abstract] [Full Text]

				B. G. Xue, E. R. Whittemore, C. H. Park, R. M. Woodward, N. C. Lan, and K. W. Gee J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1095 - 1101. [Abstract] [Full Text]

				W. J. Zhu and S. Vicini Neurosteroid Prolongs GABAA Channel Deactivation by Altering Kinetics of Desensitized States J. Neurosci., June 1, 1997; 17(11): 4022 - 4031. [Abstract] [Full Text] [PDF]

				R. Dombroski, M. L. Casey, and P. C. MacDonald Human Saturated Steroid 6{alpha}-Hydroxylase J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1338 - 1344. [Abstract] [Full Text] [PDF]

				R. B. Carter, P. L. Wood, S. Wieland, J. E. Hawkinson, D. Belelli, J. J. Lambert, H. S. White, H. H. Wolf, S. Mirsadeghi, S. H. Tahir, et al. Characterization of the Anticonvulsant Properties of Ganaxolone (CCD 1042; 3alpha -Hydroxy-3beta -methyl-5alpha -pregnan-20-one), a Selective, High-Affinity, Steroid Modulator of the gamma -Aminobutyric AcidA Receptor J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1284 - 1295. [Abstract] [Full Text]

				W. J. Zhu, J. F. Wang, K. E. Krueger, and S. Vicini delta Subunit Inhibits Neurosteroid Modulation of GABAA Receptors J. Neurosci., November 1, 1996; 16(21): 6648 - 6656. [Abstract] [Full Text] [PDF]

				M. Khanna, K.-N. Qin, R. W. Wang, and K.-C. Cheng Substrate Specificity, Gene Structure, and Tissue-specific Distribution of Multiple Human 3alpha-Hydroxysteroid Dehydrogenases J. Biol. Chem., August 25, 1995; 270(34): 20162 - 20168. [Abstract] [Full Text] [PDF]

				M Orchinik, T. Murray, and F. Moore A corticosteroid receptor in neuronal membranes Science, June 28, 1991; 252(5014): 1848 - 1851. [Abstract] [PDF]